Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Gauging the Upsides and downsides of Visas: A Complete Aide - 2Family-Accommodating Snow Sports Experiences
- 3Whale stranded off Germany for days free again
- 4Warnings rise for U.S. as severe flu strain causes outbreaks in Canada, U.K.
- 5From record warming to rusting rivers, 2025 Arctic Report Card shows a region transforming faster than expected
- Disability rights activist and author Alice Wong dies at 51
- More charges filed against ex-left-wing RAF member Daniela Klette
- Pick Your #1 Sort Of Espresso
- UB professor shares his experience on almost becoming an astronaut
- At least 490 protesters killed in Iran, activists say
- German state railway loss widens, passengers warned of trouble ahead
- From Novice to Master: Dominating a Side interest
- 5 Movies That Leaving an Imprint with Inventive Innovation
- Go on A Careful spending plan: Modest Objections for Your List of must-dos
